Systemic Therapy of Primary Cutaneous B-cell Lymphoma, Marginal Zone Type, with Rituximab, a Chimeric Anti-CD20 Monoclonal Antibody

Author: Soda R.   Costanzo A.   Cantonetti M.   Orlandi A.   Bianchi L.   Chimenti S.  

Publisher: Medical Journals Limited

ISSN: 0001-5555

Source: Acta Dermato-Venereologica, Vol.81, Iss.3, 2001-06, pp. : 207-208

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content